The importance of investing in a specialized fund in the field of stem cell science and technology
According to the report of Public Relations and International Affairs of the Council for Development of Stem Cell Science and Technology, a meeting with the presence of Dr. Hamidieh, Secretary General, Dr. Mahboudi, Chairman of the Board of Knowledge-Based Sinagen Company and Dr. Karagah, CEO of Persis Gene on April 20, 2021 in the location of Vice-Presidency for Science and Technology was held.
Dr. Hamidiyeh, referring to the extensive activities in the field of stem cells and reconstructive medicine, emphasized the importance of investing in the development of advanced products according to market needs and considered it necessary to attract the maximum number of active knowledge-based companies in this field to invest in this area.
Dr. Mahboudi further announced the company's readiness to participate in this fund and announced the increase of technological capabilities of domestic knowledge-based companies in the production of products related to this field.
ارسال به دوستان